Table 2 Characteristics of participants’ Clostridioides difficile infection (CDI)
Current CDI (n = 115) | Past CDI (n = 235) | |
|---|---|---|
Last CDI occurrence date (Past CDI) CDI occurrence start date (Current CDI) | ||
In the last week | 8 (7%) | 1 (0.4%) |
Between 1 and 2 week(s) ago | 7 (6.1%) | 4 (1.7%) |
Between 2 and 4 weeks ago | 17 (14.8%) | 2 (0.9%) |
Between 1 and 3 months ago | 30 (26.1%) | 20 (1.7%) |
Between 3 and 6 months ago | 20 (17.4%) | 24 (10.2%) |
Between 6 and 12 months ago | 16 (13.9%) | 38 (16.2%) |
More than 12 months ago | 17 (14.8%) | 146 (62.1%) |
CDI treatments | ||
Subjects remembering their CDI treatment /currently treated for CDI | 97 (84.3%) | 229 (97.4%) |
Metronidazole | 48 (49.5%) | 144 (62.9%) |
Vancomycin | 53 (54.6%) | 187 (81.7%) |
Fidaxomicin | 17 (17.5%) | 60 (26.2%) |
Fecal microbiota transplant | 10 (10.3%) | 66 (28.8%) |
Probiotics | 38 (39.2%) | 151 (65.9%) |
Other treatment | 4 (4.1%) | 22 (9.6%) |
Surgery | ||
GI surgery due to CDI | N/A | 11 (4.7%) |
Recurrences | ||
Subjects who have experienced at least one recurrence | N/A | 105 (44.7%) |